Philadelphia DA Files a Lawsuit Against Nearly 20 Pharmaceutical Companies Over Insulin Prices

Philadelphia District Attorney Larry Krasner filed a lawsuit against nearly 20 pharmaceutical companies and pharmacy benefit managers (PBMs) over, what his office called, the “artificially high” cost of insulin.

In a statement, a representative of Krasner’s office said that the suit alleges that the companies targeted in the action are in violation of the Pennsylvania Unfair Trade Practices and Consumer Protection Law.

“The lawsuit contends that PBM defendants work in concert with the manufacturers to dictate the availability and price of insulin drugs for most of the U.S. market. The PBM defendants are, at once, a) the three largest PBMs in the United States; b) the largest pharmacies in the United States; and c) housed within the same corporate enterprises as three of the largest insurance companies in the United States — Aetna (CVS Health), Cigna (Express Scripts), and UnitedHealthcare (OptumRx),” a DA’s Office spokesperson wrote.

Read the source article at NBC Philadelphia